28 related articles for article (PubMed ID: 21496428)
1. [SRC kinase inhibitor PP2 inhibits invasion and metastasis of lung cancer A549 cells by upregulating connexin43 expression].
Wang D; Liu Y; Zhao W; Wang R; Tong X; Jiang G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jul; 39(7):797-803. PubMed ID: 31340912
[TBL] [Abstract][Full Text] [Related]
2. Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (
Wang Y; Zhang Y; Wang Y; Shu X; Lu C; Shao S; Liu X; Yang C; Luo J; Du Q
Front Chem; 2021; 9():682862. PubMed ID: 34178945
[No Abstract] [Full Text] [Related]
3. [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP].
Lv J; Tian Y
Zhongguo Fei Ai Za Zhi; 2012 Sep; 15(9):501-6. PubMed ID: 22989452
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Src on proliferation and invasion of lung cancer cells].
Zheng R; Qin X; Li W; Kang J
Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):311-6. PubMed ID: 21496428
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
Zheng R; Qin X; Li W; Kang J
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):13-7. PubMed ID: 21219825
[TBL] [Abstract][Full Text] [Related]
6. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells.
Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S
Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247
[TBL] [Abstract][Full Text] [Related]
7. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness.
Ito H; Gardner-Thorpe J; Zinner MJ; Ashley SW; Whang EE
Surgery; 2003 Aug; 134(2):221-6. PubMed ID: 12947321
[TBL] [Abstract][Full Text] [Related]
9. Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer.
Ceppi P; Rapa I; Lo Iacono M; Righi L; Giorcelli J; Pautasso M; Billè A; Ardissone F; Papotti M; Scagliotti GV
Int J Cancer; 2012 Apr; 130(8):1777-86. PubMed ID: 21618517
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy: an evolving world of lung cancer.
Lam KC; Mok TS
Respirology; 2011 Jan; 16(1):13-21. PubMed ID: 20723139
[TBL] [Abstract][Full Text] [Related]
11. SRC: a century of science brought to the clinic.
Aleshin A; Finn RS
Neoplasia; 2010 Aug; 12(8):599-607. PubMed ID: 20689754
[TBL] [Abstract][Full Text] [Related]
12. Src inhibitors in lung cancer: current status and future directions.
Rothschild SI; Gautschi O; Haura EB; Johnson FM
Clin Lung Cancer; 2010 Jul; 11(4):238-42. PubMed ID: 20630825
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
